Veterinary Medicine Information website

Equinor 370 mg/g Oral Paste for Horses

Authorised
  • Omeprazole
Download as PDF

Product identification

Medicine name:
Equinor 370 mg/g Oral Paste for Horses
Active substance:
  • Omeprazole
Target species:
  • Horse
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Omeprazole
    370.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral paste
Withdrawal period by route of administration:
  • Oral use
    • Horse
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA02BC01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Immediate packageImmediate packaging: 7 ml oral syringe containing 7.57 g of paste composed of polyethylene barrel, plunger and end cap, withpolypropylene dosing rings.Outer package and sales presentations- Carton box of 1 oral syringe
  • Immediate packageImmediate packaging: 7 ml oral syringe containing 7.57 g of paste composed of polyethylene barrel, plunger and end cap, withpolypropylene dosing rings.Outer package and sales presentations- Carton box of 7 oral syringes
  • Immediate packageImmediate packaging: 7 ml oral syringe containing 7.57 g of paste composed of polyethylene barrel, plunger and end cap, withpolypropylene dosing rings.Outer package and sales presentations- Bucket of 72 oral syringes.
  • Immediate package Immediate packaging: 7 ml oral syringe containing 7.57 g of paste composed of polyethylene barrel, plunger and end cap, with polypropylene dosing rings. Outer package and sales presentations - Carton box of 14 oral syringes
  • Immediate package Immediate packaging: 7 ml oral syringe containing 7.57 g of paste composed of polyethylene barrel, plunger and end cap, with polypropylene dosing rings. Outer package and sales presentations - Carton box of 21 oral syringes

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Manufacturing Limited
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V470595
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0308/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • France
  • Germany
  • Netherlands
  • Norway
  • Poland
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 12/04/2026
Download
Dutch (PDF)
Published on: 22/04/2026
Download
French (PDF)
Published on: 22/04/2026
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 22/04/2026
Download
German (PDF)
Published on: 22/04/2026
Download
Dutch (PDF)
Published on: 22/04/2026
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 22/04/2026
Download
German (PDF)
Published on: 22/04/2026
Download
Dutch (PDF)
Published on: 22/04/2026
Download

ie-puar-mr-iev0308001-equinor-370-mgg-oral-paste-for-horses-en.pdf

English (PDF)
Published on: 23/02/2025
Download